Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Former FDA device director joins consulting firm

Executive Summary

Falls Church-Va. based NDA Partners announces former Center for Device & Radiological Health Director David Feigal, MD, will join as senior partner. Feigal originally joined FDA's Center for Drug Evaluation and Research in 1992; he also worked in the Center for Biologics Evaluation & Research. NDA Partners Chairman Carl Peck, MD, served as CDER director from 1987-1994 and helped recruit Feigal to the agency. Feigal left FDA at the end of April (1"The Pink Sheet" April 19, 2004, p. 5)...

Falls Church-Va. based NDA Partners announces former Center for Device & Radiological Health Director David Feigal, MD, will join as senior partner. Feigal originally joined FDA's Center for Drug Evaluation and Research in 1992; he also worked in the Center for Biologics Evaluation & Research. NDA Partners Chairman Carl Peck, MD, served as CDER director from 1987-1994 and helped recruit Feigal to the agency. Feigal left FDA at the end of April (1 (Also see "FDA Device Center Director Departs; Feigal Oversaw Approval Of Cypher Stent" - Pink Sheet, 19 Apr, 2004.), p. 5)....

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043922

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel